Nurcan Gumus
Izmir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 25, 2025
Pentablock thermoresponsive hydrogels for chemotherapeutic delivery in a pancreatic cancer model.
Journal: Biomaterials science
Published: February 26, 2025
Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: April 05, 2024
Charge neutralized poly(β-amino ester) polyplex nanoparticles for delivery of self-amplifying RNA.
Journal: Nanoscale advances
Published: September 19, 2023
Investigating histidinylated highly branched poly(lysine) for siRNA delivery.
Journal: Journal of materials chemistry. B
Published: December 01, 2021
STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells.
Journal: Journal of biomolecular structure & dynamics
Published: November 29, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026